Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tooth mineral demineralization is not a discrete molecular entity, receptor, enzyme, or protein, but a **physicochemical process** occurring in teeth, especially in enamel, dentin, and cementum. It refers to the loss of mineral ions (primarily calcium and phosphate) from hydroxyapatite crystals in tooth hard tissue. This process is driven by acidic conditions in the mouth, typically following consumption of carbohydrates and microbial activity, which lower pH and solubilize tooth mineral. The process is dynamic and reversible: if conditions favor remineralization (with sufficient saliva and/or fluoride), lost minerals can be restored; if demineralization dominates, progressive damage leads to dental caries (cavities) and other lesions[1][2][3][4][5]. **Therapeutic targeting** focuses not on the process itself as a "drug target," but on modifying factors (such as salivary composition, oral pH, or microbial load) or enhancing remineralization (with agents like fluoride or calcium phosphates)[2][5]. Therefore, "tooth mineral demineralization" is best classified as a pathological process, not a molecular drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tooth mineral demineralization.